Provided by Tiger Fintech (Singapore) Pte. Ltd.

Intellia Therapeutics

12.51
-0.6000-4.58%
Volume:3.16M
Turnover:39.76M
Market Cap:1.30B
PE:-2.40
High:13.19
Open:13.19
Low:12.28
Close:13.11
Loading ...

Intellia Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Intellia Therapeutics Q4 Net Loss Narrows; Shares Rise Pre-Bell

MT Newswires Live
·
27 Feb

Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
27 Feb

Intellia Therapeutics Q4 Net Income USD -128.898 Million

Reuters
·
27 Feb

Earnings Flash (NTLA) Intellia Therapeutics Posts Q4 Collaboration Revenue $12.9M, vs. FactSet Est of $8.6M

MT Newswires Live
·
27 Feb

Earnings Flash (NTLA) Intellia Therapeutics Posts Q4 Net Loss $-1.27 a Share, vs. FactSet Est of $-1.33 Loss

MT Newswires Live
·
27 Feb

Intellia Therapeutics Q4 2024 GAAP EPS $(1.27) Beats $(1.36) Estimate, Sales $12.87M Beat $8.53M Estimate

Benzinga
·
27 Feb

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Company Progress

GlobeNewswire
·
27 Feb

Praxis Precision Medicines, Inc. (PRAX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Zacks
·
25 Feb

Intellia Therapeutics Inc expected to post a loss of $1.33 a share - Earnings Preview

Reuters
·
25 Feb

What's in Store for These 5 Biotech Stocks This Earnings Season?

Zacks
·
24 Feb

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

Zacks
·
18 Feb

Will Intellia Therapeutics (NASDAQ:NTLA) Spend Its Cash Wisely?

Simply Wall St.
·
15 Feb

NTLA LAWSUIT ALERT: Levi & Korsinsky LLP Notifies Intellia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

TIPRANKS
·
12 Feb

Intellia Therapeutics Inc. (NTLA): Among Cathie Wood’s Top Stock Picks for 2025

Insider Monkey
·
07 Feb

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
05 Feb